Capital Impact Advisors, LLC Karyopharm Therapeutics Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019
SELL
$4.32 - $6.43 $662,899 - $986,677
-153,449 Closed
0 $0
Q4 2018

Mar 08, 2019
BUY
$8.2 - $16.95 $421,832 - $871,958
51,443 Added 50.43%
153,449 $1.4 Million
Q3 2018

Oct 19, 2018
BUY
$17.03 - $21.18 $1.74 Million - $2.16 Million
102,006 New
102,006 $1.74 Million

Others Institutions Holding KPTI

# of Institutions
88
Shares Held
59.3M
Call Options Held
547K
Put Options Held
67K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $395M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email